Sandbox Reserved 430: Difference between revisions

From Proteopedia
Jump to navigationJump to search
← Older editNewer edit →
Student (talk | contribs)
students
33,923 edits
No edit summary
Student (talk | contribs)
students
33,923 edits
No edit summary
Line 75: Line 75:
1. Savi, P., et al. "P2Y 12, a new platelet ADP receptor, target of clopidogrel." Biochemical and biophysical research communications 283.2 (2001): 379-383.
1. Savi, P., et al. "P2Y 12, a new platelet ADP receptor, target of clopidogrel." Biochemical and biophysical research communications 283.2 (2001): 379-383.


2. https://en.wikipedia.org/wiki/Cytochrome_P450
2. Coon, Minor J. "Cytochrome P450: nature's most versatile biological catalyst." Annu. Rev. Pharmacol. Toxicol. 45 (2005): 1-25.


3. https://en.wikipedia.org/wiki/Clopidogrel
3. Gurbel, Paul A., et al. "Clopidogrel for coronary stenting response variability, drug resistance, and the effect of pretreatment platelet reactivity." Circulation 107.23 (2003): 2908-2913.


4. https://en.wikipedia.org/wiki/P2Y12
4. Barn, Kulpreet, and Steven R. Steinhubl. "A brief review of the past and future of platelet P2Y12 antagonist." Coronary artery disease 23.6 (2012): 368-374.


5. https://en.wikipedia.org/wiki/Purinergic_signalling
5. Bodin, Philippe, and Geoffrey Burnstock. "Purinergic signalling: ATP release." Neurochemical research 26.8-9 (2001): 959-969.
Retrieved from "https://proteopedia.org/Sandbox_Reserved_430"